This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Feldman BJ and Feldman D (2001) The development of androgen-independent prostate cancer. Nat Rev Cancer 1: 34–45
Chen CD et al. (2004) Molecular determinants of resistance to antiandrogen therapy. Nat Med 10: 33–39
Debes JD and Tindall DJ (2004) Mechanisms of androgen-refractory prostate cancer. N Engl J Med 351: 1488–1490
Li R et al. (2004) High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate cancer patients treated with radical prostatectomy. Am J Surg Pathol 28: 928–934
Ayala et al. (2003) Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. Clin Cancer Res 9: 4792–4801
Acknowledgements
The synopsis was written by Sandra Michelmore, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Hamdy, F. Can androgen receptor levels in the prostate predict non-organ-confined prostate cancer?. Nat Rev Urol 2, 368–369 (2005). https://doi.org/10.1038/ncpuro0232
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro0232